This must be the joint government funded COVID-19 project in which Biotome will use AkidaTM to identify the antibodies that can protect against SARS- CoV-2 infection – the so-called neutralising antibodies, which could pave the way for a test that determines which level of protection against COVID-19 a person has after having received COVID-19 vaccination or after having been infected with SARS-CoV-2.
2022 BRN Discussion, page-5542
-
- There are more pages in this discussion • 5,381 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $366.5M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $611.6K | 3.134M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 605588 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 1228966 | 43 |
View Market Depth
| Last trade - 15.57pm 17/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |